Algorithm Sciences Stock
Algorithm Sciences is a biopharmaceutical company that focuses on treatment for rare cardiovascular diseases.
Sign up today and learn more about Algorithm Sciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Algorithm Sciences Stock
Algorithm Sciences is focused on optimizing treatment for rare Cardiovascular Diseases. It is a Laidlaw Venture Partners portfolio company.
Funding History
| April 2021 | $5.0M |
|---|
Management
Director
James Ahern
CEO & Founder
Matthew Duffy
Press
einnews - Jun, 27 2023
Lucius Partners Portfolio Company Algorithm Sciences, Inc. Completes the Purchase of Flowonix Assets (Prometra II Pump)marketwatch - May, 12 2023
Hoth Therapeutics, Algorithm Sciences Scrap Reverse Mergerdlvr - Apr, 26 2023
Hoth Therapeutics Sets Reverse Merger With Algorithm Sciencesglobenewswire - Nov, 18 2021
Algorithm Sciences, a Laidlaw Venture Partners Portfolio Company, Announces Key Management AppointmentsEquityZen Recognized As:
